Business Arrangements: 5 RED FLAGS FOR DRUGMAKER-DOC BUSINESS ARRANGEMENTS
Physicians and pharmaceutical companies are in the kickback enforcement crosshairs, as the HHS Office of Inspector General's recent compliance guidance for drugmakers makes clear.
Any time a physician gets something of value from a pharma company - whether it's a consulting fee or a free dinner - kickback concerns may come into play.
While the OIG says docs and drugmakers should fit their business arrangements into a safe harbor (such as those for personal services and management contracts) that's not always possible. But the agency does offer some advice on this tricky topic.
When the safe harbor option is...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: